Modulation of endothelial cell hemostatic properties by tumor necrosis factor
- PMID: 3753996
- PMCID: PMC2188058
- DOI: 10.1084/jem.163.3.740
Modulation of endothelial cell hemostatic properties by tumor necrosis factor
Abstract
Tumor necrosis factor/cachectin (TNF) is a mediator of the septic state, which involves diffuse abnormalities of coagulation throughout the vasculature. Since previous studies have shown that endothelial cells can play an active role in coagulation, we wished to determine whether TNF could modulate endothelial cell hemostatic properties. Incubation of purified recombinant TNF with cultured endothelial cells resulted in a time- and dose-dependent acquisition of tissue factor procoagulant activity. Concomitant with enhanced procoagulant activity, TNF also suppressed endothelial cell cofactor activity for the anticoagulant protein C pathway; both thrombin-mediated protein C activation and formation of functional activated protein C-protein S complex on the cell surface were considerably attenuated. Comparable concentrations of TNF (half-maximal affect at approximately 50 pM) and incubation times (half-maximal affect by 4 h after addition to cultures) were required for each of these changes in endothelial cell coagulant properties. This unidirectional shift in cell surface hemostatic properties favoring promotion of clot formation indicates that, in addition to leukocyte procoagulants, endothelium can potentially be instrumental in the pathogenesis of the thrombotic state associated with inflammatory and malignant disorders.
Similar articles
-
Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.Proc Natl Acad Sci U S A. 1986 May;83(10):3460-4. doi: 10.1073/pnas.83.10.3460. Proc Natl Acad Sci U S A. 1986. PMID: 3486418 Free PMC article.
-
Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties.Onkologie. 1987 Aug;10(4):254-8. doi: 10.1159/000216415. Onkologie. 1987. PMID: 2823200
-
Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.J Exp Med. 1986 Jun 1;163(6):1363-75. doi: 10.1084/jem.163.6.1363. J Exp Med. 1986. PMID: 3011946 Free PMC article.
-
Regulation of the coagulation system by vascular endothelial cells.Haemostasis. 1988;18(4-6):202-14. doi: 10.1159/000215808. Haemostasis. 1988. PMID: 2853122 Review.
-
Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding.Tex Heart Inst J. 1994;21(1):86-90. Tex Heart Inst J. 1994. PMID: 8180515 Free PMC article. Review.
Cited by
-
Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation.Immunol Res. 1986;5(4):281-93. doi: 10.1007/BF02935501. Immunol Res. 1986. PMID: 3036973 Review. No abstract available.
-
Production and enhanced anti-tumor activity of tumor necrosis factor in mice treated with cyclophosphamide.Jpn J Cancer Res. 1990 Sep;81(9):942-8. doi: 10.1111/j.1349-7006.1990.tb02671.x. Jpn J Cancer Res. 1990. PMID: 2121696 Free PMC article.
-
Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.Biochem J. 1988 Feb 15;250(1):125-32. doi: 10.1042/bj2500125. Biochem J. 1988. PMID: 3128274 Free PMC article.
-
In vitro and in vivo activation of endothelial cells by colony-stimulating factors.J Clin Invest. 1991 Mar;87(3):986-95. doi: 10.1172/JCI115107. J Clin Invest. 1991. PMID: 1705569 Free PMC article.
-
Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.Eur J Pediatr. 1990 Nov;150(1):43-7. doi: 10.1007/BF01959479. Eur J Pediatr. 1990. PMID: 1706665 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources